25Dec 2023
Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases

Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases

Researchers conducted a study with 118 metastatic breast cancer patients to assess the impact of induction treatment (BEEP) comprising bevacizumab, etoposide, and cisplatin, followed by whole-brain radiotherapy (WBRT). Results indicate a median brain-specific progression-free survival (PFS) of 8.1 months in the experimental group compared to 6.5 months in the control, suggesting potential improvement in controlling brain metastasis. While the brain-specific objective response rate at two months showed no significant difference, the 8-month brain-specific PFS rate was higher in the BEEP group. This approach could address the need for effective systemic treatment in metastatic breast cancer with brain metastasis.

  • #oncology

Like

Save

Share